Clinical utility of molecular profiling in rare lung neuroendocrine neoplasms.

Leunissen D, Moonen L, van Weert T, Heijboer F, Hillen LM, Von der Thüsen J, Speel EJ, Dingemans AM, Derks JL

Open source

DOI
10.3389/fonc.2026.1840985
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1840985,
  title = {Clinical utility of molecular profiling in rare lung neuroendocrine neoplasms.},
  author = {Leunissen D and Moonen L and van Weert T and Heijboer F and Hillen LM and Von der Thüsen J and Speel EJ and Dingemans AM and Derks JL},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1840985},
  url = {https://doi.org/10.3389/fonc.2026.1840985}
}

RIS

TY  - JOUR
TI  - Clinical utility of molecular profiling in rare lung neuroendocrine neoplasms.
AU  - Leunissen D
AU  - Moonen L
AU  - van Weert T
AU  - Heijboer F
AU  - Hillen LM
AU  - Von der Thüsen J
AU  - Speel EJ
AU  - Dingemans AM
AU  - Derks JL
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1840985
UR  - https://doi.org/10.3389/fonc.2026.1840985
ER  - 

APA

D, L., L, M., T, V. W., F, H., LM, H., J, V. D. T., EJ, S., AM, D., & JL, D. (2026). Clinical utility of molecular profiling in rare lung neuroendocrine neoplasms.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1840985

Source records